Warning: count(): Parameter must be an array or an object that implements Countable in /customers/c/7/f/aggeromedtech.com/httpd.www/wp-includes/post-template.php on line 265


NeuroFlexor is now CE-approved and available for clinical use!

web pic_v3


Movement is living!
Correct diagnosis means best treatment


New scientific publication: ”Neural and non-neural related properties in the spastic wrist flexors: An optimization study.

Sept 2017: The paper is availiable at Medical Engineering & Physics or PubMed

New scientific publication: ” Changes in Muscle Spasticity in Patients With Cerebral Palsy After Spinal Manipulation: Case Series.

Dec 2016: The paper is availiable at PubMed.

New scientific publication: ”Normative NeuroFlexor data for detection of spasticity after stroke: a cross-sectional study”

March 2016: The paper is availiable at JNER or PubMed.

NeuroFlexor mentioned in Lancet Neurology

October 2015: The paper is available through PubMed or at Lancet Neurology.

Testing the first prototype of the foot module

August 2015: The first version of the NeuroFlexor foot module is now being tested  on adults with stroke. The device will soon be launched for research purposes.

New scientific publication

December 2014: Stubbs et al. recently published a clinical commentary on the NeuroFlexor in Novel Physiotherapies:

Objective Quantification of Wrist and Finger Spasticity: An Alternative to Current Clinical Measurements: A Commentary

New submitted abstract

December 2014: Abstract submitted to ISB 2015, by Ruoli Wang et al: A Neuromusculosceletal model to simulate passive wrist extension test of spasticity.

New scientific publication

November 2014: A study on the use of NeuroFlexor in persons with Parkinson´s disease is available from the publisher´s website: Neural and Nonneural Contributions to Wrist Rigidity in Parkinson’s Disease: An Explorative Study Using the NeuroFlexor.

Meet us at TOXINS Nordic Congress in Copenhagen October 3-4 2014


Download our information brochure here.

Watch a video presentation here.

The NeuroFlexor is an objective measure of spasticity developed for clinical and research use. The NeuroFlexor separates mechanical and neuronal properties of the spastic muscle. It is a measurement instrument suitable for evaluation of rehabilitation interventions both in a clinical and a scientific setting. A common patient group is adults with stroke or traumatic brain injuries.

New scientific publication

June 2014: A study on the sensitivity to change of the NeuroFlexor is now available on PubMed: Sensitivity of the NeuroFlexor method to measure change in spasticity after treatment with botulinum toxin A in wrist and finger muscles.


March 2014: NeuroFlexor is now CE approved and is available for clinical use. Please review the EC Certificate found under Technical details

Contact info@aggeromedtech.com for more information.